Magnetic resonance in the detection of breast cancers of different histological types
- PMID: 25114543
- PMCID: PMC4089708
- DOI: 10.4137/MRI.S10640
Magnetic resonance in the detection of breast cancers of different histological types
Abstract
Breast cancer incidence is increasing worldwide. Early detection is critical for long-term patient survival, as is monitoring responses to chemotherapy for management of the disease. Magnetic resonance imaging and spectroscopy (MRI/MRS) has gained in importance in the last decade for the diagnosis and monitoring of breast cancer therapy. The sensitivity of MRI/MRS for anatomical delineation is very high and the consensus is that MRI is more sensitive in detection than x-ray mammography. Advantages of MRS include delivery of biochemical information about tumor metabolism, which can potentially assist in the staging of cancers and monitoring responses to treatment. The roles of MRS and MRI in screening and monitoring responses to treatment of breast cancer are reviewed here. We rationalize how it is that different histological types of breast cancer are differentially detected and characterized by MR methods.
Keywords: 1H nuclear magnetic resonance spectroscopy; 31P nuclear magnetic resonance spectroscopy; breast cancer; diffusion weighted imaging; dynamic contrast enhanced imaging; magnetic resonance imaging.
Figures




Similar articles
-
Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.Magn Reson Imaging. 2019 Sep;61:66-72. doi: 10.1016/j.mri.2019.05.032. Epub 2019 May 22. Magn Reson Imaging. 2019. PMID: 31128225
-
The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.Breast Cancer Res Treat. 2001 Jul;68(1):45-54. doi: 10.1023/a:1017911211090. Breast Cancer Res Treat. 2001. PMID: 11678308
-
Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.Acta Radiol. 2013 May;54(4):380-8. doi: 10.1177/0284185113475921. Epub 2013 Apr 30. Acta Radiol. 2013. PMID: 23436823
-
Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism.Metabolites. 2022 Mar 27;12(4):295. doi: 10.3390/metabo12040295. Metabolites. 2022. PMID: 35448482 Free PMC article. Review.
-
Clinical Breast MR Using MRS or DWI: Who Is the Winner?Front Oncol. 2016 Oct 28;6:217. doi: 10.3389/fonc.2016.00217. eCollection 2016. Front Oncol. 2016. PMID: 27840809 Free PMC article. Review.
Cited by
-
Discrimination between malignant and benign mass-like lesions from breast dynamic contrast enhanced MRI: semi-automatic vs. manual analysis of the signal time-intensity curves.J Cancer. 2018 Feb 12;9(5):834-840. doi: 10.7150/jca.23283. eCollection 2018. J Cancer. 2018. PMID: 29581761 Free PMC article.
-
Magnetic Resonance Angiography Shows Increased Arterial Blood Supply Associated with Murine Mammary Cancer.Int J Biomed Imaging. 2019 Jan 17;2019:5987425. doi: 10.1155/2019/5987425. eCollection 2019. Int J Biomed Imaging. 2019. PMID: 30792738 Free PMC article.
-
Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma.BMC Cancer. 2020 Sep 29;20(1):934. doi: 10.1186/s12885-020-07443-7. BMC Cancer. 2020. PMID: 32993586 Free PMC article.
-
Quantitative discrimination between invasive ductal carcinomas and benign lesions based on semi-automatic analysis of time intensity curves from breast dynamic contrast enhanced MRI.J Exp Clin Cancer Res. 2015 Mar 4;34(1):24. doi: 10.1186/s13046-015-0140-y. J Exp Clin Cancer Res. 2015. PMID: 25887917 Free PMC article.
-
"Pulsed Hypoxia" Gradually Reprograms Breast Cancer Fibroblasts into Pro-Tumorigenic Cells via Mesenchymal-Epithelial Transition.Int J Mol Sci. 2023 Jan 27;24(3):2494. doi: 10.3390/ijms24032494. Int J Mol Sci. 2023. PMID: 36768815 Free PMC article.
References
-
- Ferlay J, Héry C, Autier P, Sankaranarayanan R. Global burden of breast cancer. Breast Cancer Epidemiol. 2010:1–19.
-
- Parkin DM, Fernández LM. Use of statistics to assess the global burden of breast cancer. Breast J. 2006;12(Suppl 1):S70–80. - PubMed
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917. - PubMed
-
- Leach M, Verrill M, Glaholm J, et al. Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed. 1998;11(7):314–40. - PubMed
-
- Korkola J, DeVries S, Fridlyand J, et al. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res. 2003;63(21):7167–75. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources